Introduction
============

Hematopoietic stem and progenitor cells (HSPC) execute tightly co-ordinated self-renewal and lineage commitment programs that generate a balanced output of peripheral blood cell types. With aging, these programs undergo perturbation resulting in increased numbers and decreased function within the stem cell compartment as well as a shift in the balance of cell types produced -- namely, an increased proportion of granulocytes at the expense of erythroid and lymphoid lineages.^[@b1-1050905]--[@b4-1050905]^ Thus normal aged mice have diminished peripheral red blood cells and lymphocytes, increased circulating neutrophils and monocytes, and increased sensitivity to granulocyte-colony stimulating factor (G-CSF)-induced leukocytosis and HSPC mobilization.^[@b5-1050905],[@b6-1050905]^ The transplantability of age-related HSPC changes highlights the importance of cell-intrinsic determinants, although micro-environmental factors also exert a critical influence.^[@b7-1050905]--[@b9-1050905]^

The transcription factor RUNX3 has been characterized as a participant in neural and lymphocyte development, TGFβ signaling, and solid tumor suppression.^[@b10-1050905]--[@b14-1050905]^ Several studies have also demonstrated its repression in aged normal as well as tumor tissues, with the principal mechanism of inactivation being epigenetic alterations, particularly DNA methylation.^[@b15-1050905]--[@b18-1050905]^ Emerging data suggest a role in hematopoiesis, with zebrafish and murine loss of function studies revealing progenitor perturbations, although the extent of its role has remained unclear due to redundancy with Runx1.^[@b19-1050905]--[@b21-1050905]^ Most notably, induction of hematopoietic *Runx3* deletion in mice elicited marrow changes similar to those reported with normal aging: increased marrow colony forming units (CFU) and increased peripheral blood mobilization of CFU by G-CSF treatment.^[@b5-1050905],[@b22-1050905]^

This study shows *RUNX3* to be expressed in murine and human HSPC, where it undergoes repression and epigenetic modification during normal aging. HSPC levels of RUNX3 were found to determine developmental potential, with deficiency restricting erythropoiesis at commitment and subsequent stages while fully permitting granulopoiesis. HSPC purified from patients with unexplained anemia of aging manifested RUNX3 deficiency and similar developmental alterations. Changes in HSPC transcriptome due to *RUNX3* deficiency suggest a role upstream of the erythroid master regulatory transcription factors KLF1 and GATA1.

Methods
=======

Cell culture
------------

Human CD34^+^ expansion medium consisted of Iscove's modified Dulbecco's medium (IMDM) supplemented with bovine serum albumin, insulin and transferrin (BIT) 9500, and 100 ng/mL each of rhTPO, rhSCF, and rhFlt3-l, plus 10 ng/ml rhIL-3. Erythroid medium consisted of IMDM supplemented with BIT 9500, and 4.5 U/mL rhEPO and 25 ng/mL rhSCF. Megakaryocyte medium consisted of IMDM supplemented with BIT 9500, and 40 ng/mL rhTPO, 25 ng/mL rhSCF, and 20 ng/mL rhSDF1-alpha. Granulocyte medium consisted of IMDM supplemented with BIT 9500, and 25 ng/mL rhSCF, 10 ng/mL rhIL-3, and 20 ng/mL rhG-CSF. Colony formation assays were conducted using methylcellulose supplemented with 50 ng/mL rhSCF, 10 ng/mL rhIL-3, 20 ng/mL rhIL-6, 3 U/mL rhEPO, 20 ng/mL rhG-CSF, and 10 ng/mL rhGM-CSF.

Mass cytometry
--------------

Cells were stained for viability with 100 mM cisplatin, fixed with 1.6% paraformaldehyde, and stored at −80°C. Thawed samples were barcoded, pooled, and surface stained at room temperature for 30 minutes (min). Cells were then permeabilized with methanol and stained for intercellular antigens for 1 hour (h) at room temperature. Next, cells were incubated with Fluidigm CellID Ir-Intercalator, re-suspended in water with normalization beads, and analyzed on a Fluidigm CyTOF 2. Data were bead-normalized and underwent barcode deconvolution using the debarcoding tool MATLAB standalone executable.^[@b23-1050905]^

Data were inverse hyberbolic sine-transformed using a co-factor of 0.25. FlowSOM was used to construct a self-organizing map, and each cell was assigned a phenocode for every lineage marker using flowType. Each grid point was then immunophenotyped, and cell counts were tabulated to form a hierarchical count table. Differential abundance was tested for using edgeR with a quasi-likelihood framework as specified by the cydarTM package.

RNA-sequencing
--------------

RNA was extracted using the QIAgen RNeasy Plus Mini Kit, with added DNA digestion. Samples underwent ribosomal reduction, and sequencing with 100bp, paired-end, and 50 million read-depth parameters on an Illumina HiSeq 2500 machine. Data were processed online at [usegalaxy.org](http://usegalaxy.org). Trimmomatic was used to eliminate low quality sequences from the reads, followed by alignment to the hg19 reference genome using HISAT2, and RmDup to eliminate PCR duplicates. Differential gene expression was assessed with both DESeq2 and Cufflinks tools. The Synergizer tool was used to convert UCSC gene identifiers into hgnc gene symbols.

Unexplained anemia of the elderly studies
-----------------------------------------

Mononuclear cells were sorted phenotypically: HSC, Lin-CD34^+^CD38^--^CD904^+^ CD45RA^--^; MEP, Lin^--^CD34^+^CD38^+^CD123-CD45RA^--^. Colony assays were performed using complete methylcellulose with 12-14 days incubation. For microarray, RNA samples were quantified, subjected to reverse transcription, underwent two rounds of linear amplification, and biotinylated. 15 µg of RNA per sample was assayed using Affymetrix HG U133 Plus 2.0 microarrays. Data were analyzed using the gene expression commons platform.

Ethics statement
----------------

This study was reviewed and approved by the institutional review boards of the respective institutions and was conducted in accordance with the principles of the Declaration of Helsinki.

Data and software availability
------------------------------

RNA-sequencing accession numbers: GSE119264, GSE104406. Microarray accession number: GSE123991.

Results
=======

Hematopoietic stem cell *RUNX3* levels decline with aging
---------------------------------------------------------

Prior reports have shown marrow-specific *Runx3* knockout to elicit aspects of the aging phenotype and to exaggerate the myeloid skewing associated with aging.^[@b5-1050905],[@b22-1050905]^ We therefore assessed *RUNX3* expression in rigorously purified human and murine hematopoietic stem cells. In humans, RNA-seq has been conducted on Lin^--^CD34^+^CD38^--^ marrow cells from healthy young (18-30 years old) and aged (65-75) subjects (GSE104406). In mice, side population (SP) Lin^--^Sca^+^Kit^+^CD150^+^ marrow cells from young (4 months old) and aged (24 months) animals have undergone RNA-seq3 (GSE47819). Both datasets demonstrated HSC expression of RUNX3 with significant decreases associated with aging ([Figure 1A and B](#f1-1050905){ref-type="fig"}). Human CD34^+^CD38^+^ later stage progenitors also showed diminished *RUNX3* expression with aging, indicating that the changes are not HSC-restricted (*Online Supplementary Figure S1A*). Evidence for an aging-associated decline in progenitor protein levels was seen in human marrow samples immunostained for *RUNX3* (*Online Supplementary Figure S1B*). Analysis of murine bone marrow single-cell RNA-seq datasets^[@b24-1050905]^ (GSE89754) from animals with or without erythropoietin (EPO) treatment confirmed that the signals for *Runx3* expression came from multipotent and early committed erythroid progenitors rather than contaminant lymphocytes. Discrimination of HSC *versus* MPP compartments is not possible by this approach (*Online Supplementary Figure S1C*).

![Hematopoietic stem and progenitor cells (HSPC) and SPC *RUNX3* levels decline with aging. (A) Human *RUNX3* mRNA levels in Lin^--^CD34^+^CD38^--^bone marrow (BM) HSPC obtained from healthy young and aged individuals. N=10 per group. (B) Mouse *Runx3* mRNA levels in side population, Lin^--^Sca1^+^Kit^+^CD150^+^ BM HSC obtained from healthy young and aged animals (GSE478193). N=4 per group. (C and D) Tracks for DNA methylation by whole genome bisulfite sequencing (WGBS, red) and RNA-seq read counts (green) within the mouse Runx3 locus in HSC from healthy young and aged animals (GSE47819^[@b3-1050905]^). The blue box highlights the DNA methylation trough associated with the P2 promoter. (D) Mean methylation density (% of CpG reads with methylation) within trough. N=5-6 per group. (E-G) Histone H3K27 acetylation by chromatin immunoprecipitation (ChIP)-sequencing within the human locus in HSPC from healthy young and aged individuals. Gray shading highlights peaks within the P2 promoter and upstream super-enhancer. (F) H3K27ac score for the P2 promoter peak, and (G) the sum of peak scores across the enhancer. N=4-5 per group. All statistics two-tailed Student *t*-test, except in F: log likelihood ratio (LLR). Error bars+standard error of mean. FPKM: fragments per kilobase of transcript per million.](105905.fig1){#f1-1050905}

Because epigenetic changes occur with HSC aging and participate in regulation of RUNX3,^[@b25-1050905]--[@b27-1050905]^ we investigated the effect of aging on DNA and histone modifications within the murine and human loci. Analysis of comprehensive DNA methylation mapping by whole genome bisulfite sequencing^[@b3-1050905]^ (GSE47819) revealed significant increases in P2 promoter methylation in aged murine HSC ([Figure 1C and D](#f1-1050905){ref-type="fig"}). Datasets for H3K27ac in young *versus* aged murine HSC are not currently available. The human RUNX3 locus showed aging-associated decreases in H3K27ac within the P2 promoter, as well as the super-enhancer region located approximately 97 kilobases upstream of the P2 promoter28 (GSE104406) ([Figure 1E-G](#f1-1050905){ref-type="fig"}).

RUNX3 in human hematopoietic stem and progenitor cells participates in erythroid programming
--------------------------------------------------------------------------------------------

The decline in HSC RUNX3 levels with aging illustrated in [Figure 1A](#f1-1050905){ref-type="fig"} raised questions about potential roles in human hematopoietic differentiation. Human CD34^+^ HSPC cultures were used to examine protein expression and function. By immunoblot, the initial undifferentiated population displayed relatively high *RUNX3* levels, with a gradual decline occurring during erythroid differentiation (*Online Supplementary Figure S2A*). Immunofluorescent staining revealed predominantly cytoplasmic localization in the undifferentiated cells and enhanced nuclear localization associated with erythroid differentiation (*Online Supplementary Figure S3*). Transduction of HSPC with empty or *RUNX3*-targeting lentiviral shRNA vectors did not alter the localization of *RUNX3* in erythroid differentiated cells. Both nuclear and cytoplasmic patterns of *RUNX3* localization have been observed in prior studies, and may reflect SMAD or STAT activation status as previously described.^[@b29-1050905]--[@b32-1050905]^

Partial knockdown of RUNX3 with three independent lentiviral short RNA hairpins blocked erythroid differentiation of CD34^+^ progenitors, preventing expression of glycophorin A (CD235a) ([Figure 2A](#f2-1050905){ref-type="fig"} and *Online Supplementary Figure S2B*). Subsequent experiments employed short hairpin \#4 due to robust knockdown (approx. 60% protein loss) with no significant cross-inhibition of other RUNX proteins (*Online Supplementary Figure S2C*). As additional controls, CD34^+^ progenitors also underwent transduction with shRNA vectors targeting GFP, which had no effect on erythroid differentiation, and *RUNX1*, which slightly enhanced erythroid differentiation as described^[@b33-1050905]^ (*Online Supplementary Figure S2D and E). RUNX3* deficiency in CD34^+^ HSPC also blocked erythroid colony formation in semi-solid medium, with no significant impact on monocyte or mixed granulocyte-monocyte colonies ([Figure 2B](#f2-1050905){ref-type="fig"}). As with the colony assays, *RUNX3* deficiency caused minimal changes in granulocyte differentiation (CD15) after eight days of suspension culture ([Figure 2C](#f2-1050905){ref-type="fig"}). When maintained in unilineage, serum-free erythroid medium containing EPO and stem cell factor (SCF), *RUNX3*-deficient progenitors showed time-dependent declines in proliferation and viability ([Figure 2D and E](#f2-1050905){ref-type="fig"}). By contrast, *RUNX3*-deficient progenitors cultured in expansion medium with SCF, IL-3, thrombopoietin (TPO), and Flt3-ligand retained normal proliferation and near-normal viability ([Figure 2D and E](#f2-1050905){ref-type="fig"}). However, *RUNX3* knockdown did prevent HSPC upregulation of CD41 in megakaryocytic cultures, suggesting an influence at the level of erythromegakaryocytic progenitors (*Online Supplementary Figure S2F*).

![RUNX3 participates in erythroid but not granulocytic differentiation of human progenitors. (A) Flow cytometry plots for erythroid differentiation of CD34^+^ cells transduced with empty vector (EV) or RUNX3-targeting (RUNX3 sh4) lentiviral shRNA constructs and subjected to unilineage erythroid culture for three days. Graph summarizes the quantitation of erythroid differentiation from three independent experiments. (B) Summary of colony formation assays on CD34^+^ cells transduced as in (A). (C) Flow cytometry histogram overlays for granulocyte differentiation of CD34^+^ cells transduced as in (A) and subjected to unilineage granulocytic culture for eight days. Representative results from three independent experiments. (D) Flow cytometry histogram overlays for cell proliferation by dye dilution. Transduced CD34^+^ cells were stained with PKH26 followed by three days of culture in expansion medium (CD34) or erythroid medium. Graph summarizes mean fluorescence intensity due to dye retention from three independent experiments. (E) Summary of viability as assessed by flow cytometry on CD34^+^ cells transduced as in (A) and cultured in expansion or erythroid medium for indicated days. (F) Flow cytometry plots for erythroid differentiation of CD36^+^ CD235a^--^ early committed erythroid progenitors transduced as in (A) and cultured in erythroid medium for three days. Graph summarizes quantitation of erythroid differentiation from three independent experiments. (G and H) Summary of hemoglobinization, i.e. percent cells positive for benzidine staining, in HUDEP-2 cells transduced with control vectors (EV), RUNX3-knockdown lentivirus (sh4), or RUNX3-overexpression retrovirus (OE). Cells were cultured 48 hours in HUDEP-2 expansion (Uninduced) or differentiation (Induced) medium. N=3. (A and C) Two-tailed Student *t*-test. (B, D, and F-H) Two-way ANOVA with Bonferroni's test. (E) One-way ANOVA with Tukey's test. \**P*\<0.05; \*\**P*\<0.01; \*\*\**P*\<0.005. Error bars+standard error of mean.](105905.fig2){#f2-1050905}

To determine contributions to post-commitment human erythropoiesis, we knocked down *RUNX3* in sorted CD36^+^CD235a^--^ early erythroid progenitors. *RUNX3* deficiency in these cells impaired their progression to the more mature CD36^+^CD235a^+^ stage, indicating involvement in post-commitment differentiation ([Figure 2F](#f2-1050905){ref-type="fig"}). Knockdown of RUNX3 in the human HUDEP-2 pro-erythroblast line shifted the cells to a less mature phenotype, characterized by increased CD71 and diminished CD235a expression, and blocked induction of hemoglobinization ([Figure 2G](#f2-1050905){ref-type="fig"} and *Online Supplementary Figure S2G-I*). Conversely, retroviral overexpression of RUNX3 in HUDEP-2 pro-erythroblasts enhanced their hemoglobinization ([Figure 2H](#f2-1050905){ref-type="fig"} and *Online Supplementary Figure S2I*).

Progenitor deficiency of RUNX3 alters the balance of lineage output
-------------------------------------------------------------------

To analyze in greater detail the effects of RUNX3 deficiency on progenitor fates, mass cytometry (CyTOF) was employed for comprehensive single cell profiling of cells in HSPC expansion culture, and cells in erythroid, megakaryocyte, or granulocyte culture conditions for 48 h. Cells from each culture condition were clustered into populations defined by surface marker staining, followed by construction of minimum spanning tree (MST) plots describing average fold changes in population abundance associated with RUNX3 knockdown ([Figure 3A](#f3-1050905){ref-type="fig"} and *Online Supplementary Figure S4A and B*). These populations segregated into two main branches: a lower erythro-megakaryocytic compartment (Ery/Mk: red oval) defined by CD36 and/or CD41 positivity, and an upper compartment (Myeloid: blue oval) lacking both markers (*Online Supplementary Figure S4C and D*). As expected from results in [Figure 2](#f2-1050905){ref-type="fig"}, RUNX3 knockdown selectively diminished cell populations within the Ery/Mk compartment in lineage culture conditions, but not in HSPC expansion conditions ([Figure 3A](#f3-1050905){ref-type="fig"} and *Online Supplementary Figure S4A*). This contraction was associated with impaired proliferation, as reflected by decreased Ki-67 expression, but with no evidence of increased apoptosis ([Figure 3B and C](#f3-1050905){ref-type="fig"}).

![RUNX3 levels influence progenitor lineage output balance. (A) Minimum spanning tree plots depicting cell population-nodes identified by cytometry on a Fluidigm CyTOF 2 on indicated cultures of transduced CD34^+^ progenitors. Heatmap coloration of nodes reflects log2(fold changes) in their frequency associated with RUNX3 knockdown. Erythroid-megakaryocytic (Ery/Mk) and myeloid compartments are indicated by red and blue ovals, respectively. (B and C) CyTOF histogram overlays from transduced progenitors cultured in erythroid medium, comparing expression of Ki-67 and cleaved caspase-3 between control (EV, black) and RUNX3-deficient (RUNX3 sh4, orange) populations in the Ery/Mk compartment. (D-F) CyTOF histogram overlays from transduced progenitors cultured in erythroid medium, comparing expression of CD123, CD45RA, and CD11b between control (EV, black) and RUNX3-deficient (RUNX3 sh4, orange) populations in the Ery/Mk compartment. (G) Frequencies of megakaryocyte-erythroid progenitors (MEP), common myeloid progenitors (CMP), and granulocyte-monocyte progenitor (GMP) populations calculated from all cells cultured in erythroid medium. (H and I) Histogram overlays comparing CD36, CD235a, CD71, and CD11b expression between control (EV, black) and RUNX3-deficient (RUNX3 sh4, orange) MEP and CMP.](105905.fig3){#f3-1050905}

Notably, populations in the myeloid compartment (blue oval) were augmented in RUNX3-deficient progenitors grown in erythroid medium but not in other culture conditions. Analysis of these populations revealed a myeloid-skewed shift in HSPC distribution, similar to what has been described in aged bone marrow. These populations displayed a GMP (granulocyte-monocyte progenitor) phenotype, based on expression of CD34, CD38, CD123, and CD45RA in various combinations (*Online Supplementary Table S1*). Strikingly, RUNX3-deficient populations in the Ery/Mk compartment (red oval) exhibited aberrant retention of CD123, as well as global upregulation of the GMP marker CD45RA and the myeloid differentiation antigen CD11b ([Figure 3D-F](#f3-1050905){ref-type="fig"}).

The CyTOF panel permitted assessment of the frequencies of cells with marker profiles of megakaryocyte-erythroid progenitors (MEP), common myeloid progenitors (CMP), and granulocyte monocyte progenitors (GMP).^[@b34-1050905]^ This analysis showed RUNX3 deficiency to decrease MEP frequency and increase CMP and GMP frequencies ([Figure 3G](#f3-1050905){ref-type="fig"} and *Online Supplementary Figure S4E*). Within the CMP and MEP compartments, knockdown of RUNX3 was associated with diminished expression of erythroid markers CD36 and CD235a, but enhanced expression of the myeloid marker CD11b ([Figure 3H and I](#f3-1050905){ref-type="fig"} and *Online Supplementary Figure S4F*).

RUNX3 deficiency causes perturbations in erythroid transcriptional program
--------------------------------------------------------------------------

To identify the genes affected by RUNX3 knockdown, we performed mRNA sequencing on undifferentiated CD34^+^ cells and cells in erythroid culture for 24 h, before cell viability was impacted by RUNX3 deficiency. In line with our other data, few changes were found between control and RUNX3-deficient undifferentiated cells (\<70 genes with differential expression). However, among the down-regulated genes were key erythroid transcription factors including *KLF1, GATA1*, and *GFI1B* ([Figure 4A](#f4-1050905){ref-type="fig"}). Several globin- and erythroid blood group antigen-encoding genes were decreased as well (*data not shown*). Notably, Klf1, Gata1, and downstream erythroid target genes Gypa and Epor also underwent downregulation in aged *versus* young murine HSC ([Figure 4B](#f4-1050905){ref-type="fig"}). When comparing control and RUNX3-deficient progenitors in erythroid culture, approximately 1,100 genes showed differential expression. These included many of the same genes affected in the undifferentiated cells as well as additional erythroid genes such as CD36 and EPOR ([Figure 4A](#f4-1050905){ref-type="fig"}). In addition, several granulocytic transcription factors were aberrantly up-regulated, including GFI1, JUN, and FOS ([Figure 4A](#f4-1050905){ref-type="fig"}). Gene ontology (GO) analysis of genes differentially expressed in control *versus* RUNX3-deficient undifferentiated progenitors revealed only two significant functional categories, oxygen transport (i.e. erythroid; \>100-fold enrichment; FDR 1.22E-6) and blood coagulation (i.e. megakaryocytic; 15.08-fold enrichment; FDR 1.91E-3), both of which showed downregulation. GO analysis of progenitors in erythroid culture yielded similar results but also included genes related to mitochondrial protein synthesis/transport and ribosomal biogenesis ([Figure 4C](#f4-1050905){ref-type="fig"}).

![RUNX3 deficiency causes perturbations in erythroid transcriptional program. (A) Fragments per kilobase of transcript per million (FPKM) read counts of relevant genes in transduced progenitors cultured in expansion or erythroid medium. N=3. (B) FPKM read counts of key erythroid genes in young and aged murine hematopoietic stem cells (HSC) as in [Figure 1B](#f1-1050905){ref-type="fig"} (GSE478193). (C) Gene Ontology classification by biological process of gene sets significantly down-regulated in association with RUNX3 deficiency in cells undergoing erythroid culture. N=3. All statistics False Discovery Rate (FDR), denoted by '\#' in (A) (DESeq2), plus two-tailed Student *t*-test for FPKM values denoted by asterisks in (A). \**P*≤0.05; \*\**P*≤0.01; \*\*\**P*≤0.005. Error bars±standard error of mean. EV: control vectors.](105905.fig4){#f4-1050905}

Hematopoietic stem and progenitor cells RUNX3 deficiency occurs in human anemias associated with aging
------------------------------------------------------------------------------------------------------

Because RUNX3 expression levels strongly influence human erythroid differentiation, its downregulation could potentially contribute to anemias associated with aging. To address this possibility, we analyzed highly purified marrow progenitors from the following subjects: normal non-anemic young (20-35 years old), non-anemic aged (\>65 years old), and aged (\>65 years old) subjects with unexplained anemia of the elderly (UAE). The diagnosis of UAE was made by ruling out all other potential causes of anemia, as per the criteria of Goodnough and Schrier.^[@b35-1050905]^ Gene expression profiling by microarray confirmed RUNX3 downregulation in UAE *versus* aged HSC4 (GSE32719) ([Figure 5A](#f5-1050905){ref-type="fig"}). Functional studies revealed intrinsic differences in lineage output between UAE and non-anemic old progenitors. UAE HSC yielded fewer erythroid colonies (BFU-E) but similar numbers of myeloid colonies (CFU-GM) ([Figure 5B](#f5-1050905){ref-type="fig"}). These findings resemble the effects of RUNX3 knockdown on colony formation by CD34^+^ progenitors ([Figure 2B](#f2-1050905){ref-type="fig"}). Furthermore, UAE MEP also showed poor TGFβ responsiveness in erythroid colony (CFU-E) enhancement ([Figure 5C](#f5-1050905){ref-type="fig"}), a notable finding given the known influences of HSC aging and RUNX3 expression on this pathway.^[@b3-1050905],[@b36-1050905]^

![Decreased *RUNX3* expression and impaired erythropoiesis in unexplained anemia of the elderly. (A) Log~2~\[signal\] derived from microarray analysis of *RUNX3* mRNA levels in purified human marrow hematopoietic stem cells (HSC) and common myeloid progenitors (CMP) from normal old and unexplained anemia of the elderly (UAE) subjects. N=4-8 per group. (B) Summary of colony formation assays on 150 HSC from normal young, normal old, and UAE subjects. N=3-6 per group. (C) Summary of erythroid colony formation assays ± TGFβ on 150 megakaryocyte-erythroid progenitors (MEP) from normal young *versus* UAE subjects. (A) Two-tailed Student *t*-test. (B) One-way ANOVA with Tukey's Test. (C) Two-way ANOVA with Bonferroni's test. \**P*≤0.05; \*\**P*≤0.01; \*\*\**P*≤0.005. Error bars+standard error of mean. CFU-E: colony forming unit erythroid; BFU-E: burst forming unit erythroid; CFU-GM: granulocyte-macrophage progenitor.](105905.fig5){#f5-1050905}

Discussion
==========

Hematopoietic stem cell alterations with aging are complex; they result from cell-autonomous and micro-environmental mechanisms, and involve transcriptional changes in numerous genes. Interestingly, several of the transcriptional programs affected have been previously linked to RUNX3 function, including quiescence, DNA-damage responsiveness, and TGFβ signaling.^[@b12-1050905],[@b20-1050905],[@b26-1050905],[@b36-1050905],[@b37-1050905]^ Decreased *RUNX3* in aged tissues has been previously reported but was analyzed in heterogeneous mixtures of mature cell types.^[@b15-1050905]--[@b18-1050905]^ Our results derive from purified, long-lived stem cells and reveal conservation between mice and humans. The repressive mechanism likely relates to the aging-associated epigenetic changes identified. Beerman *et al*. have shown that murine HSC aging and proliferative stress reconfigure the DNA methylation landscape, with key erythroid and lymphoid regions targeted for hyper-methylation and repression.^[@b6-1050905]^ The increased *Runx3* P2 promoter methylation we identified in aged murine HSC has also been found in aging of other tissues and cancers.^[@b16-1050905],[@b27-1050905],[@b38-1050905]^ The aging-associated decreases in H3K27ac that we identified at the human *RUNX3* promoter and upstream super-enhancer may contribute to its repression in human HSC.

A feature of HSC aging conserved from mice to humans consists of myeloid skewing characterized by augmented marrow production of neutrophils and monocytes at the expense of erythroid and lymphoid cells.^[@b1-1050905]--[@b3-1050905]^ RUNX3 deficiency in aged mice likewise yields increased myelopoiesis; however, it presents as a myeloproliferative disorder, which appears to be distinct from age-associated myeloid skewing due to lack of B-cell and T-cell perturbations, and a relatively mild erythroid deficit that may be secondary to leukocytosis.^[@b22-1050905]^ Despite these differences, our study indicates that loss of RUNX3 diminishes the expression of genes required for the erythroid program, and potentially de-represses myeloid genes. Epigenetic and transcriptomic analysis of aged HSC have also indicated that myeloid-skewing may manifest after similar changes.^[@b6-1050905],[@b7-1050905]^ Other aging-like phenotypes of RUNX3 deficiency include expansion of the LSK^+^ HSPC compartment, and increased HSPC mobilization in response to G-CSF.^[@b22-1050905]^ Thus, loss of RUNX3 contributes to age-associated HSPC phenotypes, although likely cooperates with other perturbations to generate *bona fide* myeloid-skewing.

Additional studies have implicated RUNX3 in non-lymphoid hematopoietic development. In human CD34^+^ cell erythroid cultures, RUNX3 was predicted by Cytoscape MiMI analysis of gene expression profiles to be a "parent protein," i.e. a central node, in an erythroid transcription factor network.^[@b39-1050905]^ In zebrafish, morpholino knockdown of *runx3* during embryogenesis resulted in severe anemia.^[@b19-1050905]^ Our results define a novel role for RUNX3 in the erythropoietic program, governing the expression of lineage-specific transcription factors such as *KLF1, GATA1*, and *GFI1B*. Notably, Klf1 and Gata1 displayed downregulation in aged murine HSC. We further show that RUNX3 deficiency produces perturbations at multiple developmental stages including MEP and committed erythroid progenitors. The decreased proliferation seen in RUNX3-deficient progenitors may contribute to differentiation impairment. However, the retained capacity for myeloid differentiation and the aberrant retention of GMP markers such as CD123 and CD45RA on RUNX3 deficient cells suggests an additional role in lineage resolution. Taken together, the current findings implicate RUNX3 in the maintenance of bone marrow lineage balance and identify its decline in aged HSPC as a likely contributory factor in aging-associated anemias.
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